Transplant (Hematologic) Cancer Studies Currently Recruiting Participants at the University of Chicago Comprehensive Cancer Center

Study Number Title
10-064-B Molecular characterization of hematopoietic malignancies
15147A Collection of Research Blood and/or Marrow Samples in Donors Undergoing Bone Marrow, Stem Cell or Lymphocyte Collection.
12-1856 The University of Chicago Transplant Immunology and Immunogenetics Laboratory Research Registry and Specimen Collection Protocol for Biomedical Research
IRB12-1191 Pilot study of Prophylactic Dose-Escalation Donor Lymphocyte Infusion After T Cell Depleted Allogeneic Stem Cell Transplant in High Risk Patients With Hematologic Malignancies
IRB12-1924 A Prospective Study of Optimal Cord Selection for Haplo-Cord Transplantation: Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen (NIMA)
IRB14-0711 A Phase I, Multicenter, Open-Label, Dose-Escalation Combination Study Of Pomalidomide, Marizomib, And Low-Dose Dexamethasone (PMD) In Subjects With Relapsed Or Refractory Multiple Myeloma.
12993B Collection and Use of Mobilized Peripheral Blood Stem Cells from Patients with Hematologic Malignancies
15953A Protocol for a research database for hematopoietic Stem Cell Transplanation and Marrow Toxic Injuries _ REPLACES 13239B
IRB14-0569 A Pilot Study Examining the Use of an Interdisciplinary Educational Checklist for Allogeneic Stem Cell Transplant Patients
15961A Protocol for a Research Sample Repository For Allogeneic Hematopioetic Stem Cell Transplanation_ REPLACES 12590A
11-0118 KIR Genotyping for Unrelated Donor (URD) Selection Prior to Hematopoietic Cell Transplantation (HCT) for AML: Selecting a Favorable KIR Donor

To learn more about cancer clinical trials or to make an appointment, call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials). Although our objective is to provide an updated listing of clinical trials, please note that a listing here does not guarantee that a trial is open or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating physician.